Vittorio Pengo

Associate Professor of Cardiology

University of Padua

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Immunology Immunology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Vittorio Pengo is an Associate Professor of Cardiology at the University of Padua, Italy. His research focuses on anticoagulation therapy, particularly in the context of atrial fibrillation, antiphospholipid syndrome, and associated thromboembolic risks. He has contributed to several recent publications examining the safety and efficacy of various anticoagulants, laboratory detection of antiphospholipid antibodies, and clinical characteristics of patients with thrombotic events.

Articles (24)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Collaborators (10)

pasquale pignatelli

Sapienza University of Rome

ITALY

View details

Savino Sciascia

ITALY

View details

Anna Falanga

Full Professor of Hematology

University of Milano-Bicocca

ITALY

View details

Hugo ten Cate

Professor

NETHERLANDS

View details

BENILDE COSMI

Associate Professor

University of Bologna

ITALY

View details

Nicola Pozzi

Associate Professor

Saint Louis University

UNITED STATES

View details

CHARY LOPEZ-PEDRERA

Head of Research

SPAIN

View details

Maria Laura Bertolaccini

King’s College London

UNITED KINGDOM

View details

Hannah Cohen

University College London Hospitals NHS Foundation Trust

UNITED KINGDOM

View details

Howard Belmont

Professor (Clinical) of Medicine

NYU School of Medicine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Vittorio Pengo

Research Interests

Explore related searches

Contact this professor

About

Articles (24)

Comment on<b> "</b>Apixaban <i>vs.</i> aspirin for stroke prevention in people with subclinical atrial fibrillation and a history of stroke or transient ischemic attack: subgroup analysis of the ARTESiA randomized controlled trial"

Lupus anticoagulant and antiprothrombin antibodies: embracing the future

ANA-positive versus ANA-negative Antiphospholipid Antibody-positive Patients: Results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Clinical Database and Repository (“Registry”)

An update on laboratory detection and interpretation of antiphospholipid antibodies for diagnosis of antiphospholipid syndrome: guidance from the ISTH-SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies: reply

Thrombocytopenia and autoimmune hemolytic anemia in antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid syndrome alliance for clinical trials and InternatiOnal networking (APS ACTION) clinical database and repository (“Registry”)

An update on laboratory detection and interpretation of antiphospholipid antibodies for diagnosis of antiphospholipid syndrome: guidance from the ISTH-SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies

Non-vitamin K oral anticoagulants in valvular heart disease before surgery: a tale of bridging vs. no bridging

Patients with antiphospholipid syndrome and a first venous or arterial thrombotic event: clinical characteristics, antibody profiles and estimate of the risk of recurrence

The warfarin renaissance

Inappropriate Underdosing of Direct Oral Anticoagulants in Atrial Fibrillation Patients: Results from the START2-AF Registry

Viewpoint: Provoked thrombosis in antiphospholipid syndrome

Rituximab in lupus anticoagulant hypoprothrombinemia syndrome: A case report

The safety of available pharmacotherapy for stroke prevention in atrial fibrillation

Damage measured by Damage Index for Antiphospholipid Syndrome (DIAPS) in antiphospholipid antibody-positive patients included in the APS ACTION registry

Antiphospholipid antibodies in chronic thromboembolic pulmonary hypertension

"How we treat" clinical dilemmas in antiphospholipid syndrome: A case-based approach

Anti-Neutrophil Extracellular Trap Antibodies in Antiphospholipid Antibody-Positive Patients: Results From the Antiphospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking Clinical Database and Repository

Association between Severe Acute Respiratory Syndrome Coronavirus 2Infection (Coronavirus Disease 2019) and Lupus Anticoagulant-Hypoprothrombinemia Syndrome: A Case Report and Literature Assessment

Associations Among Antiphospholipid Antibody Types, Isotypes, and Titers: An AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Study

Direct Oral Anticoagulants vs Vitamin K Antagonists in Patients With Antiphospholipid Syndromes Meta-Analysis of Randomized Trials

Fluctuation of Anti-Domain 1 and Anti-beta(2)-Glycoprotein I Antibody Titers Over Time in Patients With Persistently Positive Antiphospholipid Antibodies

New pharmacotherapeutic options for oral anticoagulant treatment in atrial fibrillation patients aged 65 and older: factor XIa inhibitors and beyond

Descriptive analysis of patients positive for anti-phospholipid antibodies included in two Italian registries

Immunosuppression use in primary antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (“Registry”)

Collaborators (10)

pasquale pignatelli

Savino Sciascia

Anna Falanga

Hugo ten Cate

BENILDE COSMI

Nicola Pozzi

CHARY LOPEZ-PEDRERA

Maria Laura Bertolaccini

Hannah Cohen

Howard Belmont

Make your next move.